XML 22 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Equity - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Total NeoStem, Inc. Shareholders' Equity [Member]
Non-Controlling Interest in Subsidiary [Member]
Beginning Balance (in shares) at Dec. 31, 2012   10,000 16,375,365            
Beginning Balance at Dec. 31, 2012 $ 32,820,159 $ 100 $ 16,375 $ 231,218,615 $ 0 $ (197,392,361) $ (665,600) $ 33,177,129 $ (356,970)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (39,485,334)         (38,981,244)   (38,981,244) (504,090)
Share-based compensation (in shares)     513,912            
Share-based compensation (6,838,559)   $ (514) (6,878,187)     (40,142) (6,838,559)  
Proceeds from issuance of common stock (in shares)     9,712,724            
Proceeds from issuance of common stock 58,736,166   $ 9,713 58,726,453       58,736,166  
Proceeds from option exercises, shares     31,369            
Proceeds from exercise of options 150,658   $ 31 150,627       150,658  
Proceeds from warrant exercises (in shares)     563,167            
Proceeds from warrant exercises 3,028,241   $ 564 3,027,677       3,028,241  
Warrant inducements     0            
other comprehensive income, foreign currency translation elimination on sale of segment         0        
Stock Issued During Period, Value, Warrant Inducements 62,014   $ 0 62,014       62,014  
Change in Ownership in Subsidiary 0     (345,020)       (345,020) 345,020
Ending Balance (in shares) at Dec. 31, 2013   10,000 27,196,537            
Ending Balance at Dec. 31, 2013 62,026,435 $ 100 $ 27,197 299,594,525 0 (236,373,605) (705,742) 62,542,475 (516,040)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (55,466,246)         (54,872,933)   (54,872,933) (593,313)
Marketable Securities, Unrealized Gain (Loss) 1,329       1,329     1,329  
Share-based compensation (in shares)     916,359            
Share-based compensation (11,209,542)   $ (916) (11,208,626)     0 (11,209,542)  
Proceeds from issuance of common stock (in shares)     2,959,214            
Proceeds from issuance of common stock 16,710,645   $ 2,959 16,707,686       16,710,645  
Proceeds from option exercises, shares     48,987            
Proceeds from exercise of options 271,008   $ 49 270,959       271,008  
Proceeds from warrant exercises (in shares)     333,250            
Proceeds from warrant exercises 1,720,725   $ 333 1,720,392       1,720,725  
Stock Issued During Period, Shares, Acquisitions     5,329,510            
Stock Issued During Period, Value, Acquisitions 21,600,351   $ 5,330 21,595,021       21,600,351  
Change in Ownership in Subsidiary 0     (668,306)       (668,306) 668,306
Ending Balance (in shares) at Dec. 31, 2014   10,000 36,783,857            
Ending Balance at Dec. 31, 2014 58,073,789 $ 100 $ 36,784 350,428,903 1,329 (291,246,538) (705,742) 58,514,836 (441,047)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net loss (81,010,501)         (80,885,952)   (80,885,952) (124,549)
Marketable Securities, Unrealized Gain (Loss) (843)       (843)     (843)  
Share-based compensation (in shares)     928,000            
Share-based compensation (9,750,110)   $ (928) (9,751,077)     (1,895) (9,750,110)  
Proceeds from issuance of common stock (in shares)     19,021,155            
Proceeds from issuance of common stock 36,471,269   $ 19,021 36,452,248       36,471,269  
Proceeds from exercise of options 0                
Change in Ownership in Subsidiary 0     (135,887)       (135,887) 135,887
Ending Balance (in shares) at Dec. 31, 2015   10,000 56,733,012            
Ending Balance at Dec. 31, 2015 $ 23,283,824 $ 100 $ 56,733 $ 396,496,341 $ 486 $ (372,132,490) $ (707,637) $ 23,713,533 $ (429,709)